Journal
PLANT PHYSIOLOGY AND BIOCHEMISTRY
Volume 127, Issue -, Pages 561-572Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.plaphy.2018.04.034
Keywords
Vaccinium; Transcriptome; Flavonoid biosynthesis; Anthocyanin biosynthesis; Fruit development
Categories
Funding
- Ministry of Agriculture Special Public Welfare Industry [201303073-04]
- Special National Key Research and Development Plan [2017YFD0400704]
Ask authors/readers for more resources
Blueberry (Vaccinium, family Ericaceae) is well known for its strong antioxidant properties and abundant active ingredients including anthocyanins, flavonols, and proanthocyanidins. In this study, variations in anthocyanin and phenolic compounds content in Bluecrop and Northblue blueberry cultivar fruits were studied, and comparative transcriptome analysis was performed to analyze differences in the molecular mechanisms of anthocyanin biosynthesis. A total of 13 799 unique genes were identified by differential expression analysis, and further subjected to GO classification and pathway enrichment. Nine differentially expressed genes (DEGs), including CHI, DFR, F3'H, FLS, CHS, OMT, UGT, ANS and F3H, were selected to validate the differential expression data using quantitative real-time PCR. The obtained qRT-PCR expression results were consistent with the RNA-Seq results. The expression levels of 9 candidate genes involved in flavonoid biosynthesis and metabolism were concurrent with the anthocyanin content. The developmental stage appeared to affect the expression of genes related to flavonoid biosynthesis to a greater extent than the tissue or cultivar type. This study provides an abundant data resource that will further our understanding of the molecular mechanisms of anthocyanin biosynthesis in blueberries.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available